NGNE Neurogene Inc
70
$33.31
$0.41
(1.22%)
| Watchers | 70 |
| 52-Wk Low | $12.20 |
| 52-Wk High | $53.00 |
| Market Cap | $432.37M |
| Volume | 49,599.00 |
| 52-Wk High | $53.00 |
| 52-Wk Low | $12.20 |
Neurogene Reports First Quarter 2024 Financial Results and Highlights Recent UpdatesBusiness Wire • 10 days ago
Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced first quarter...
Share to Feed
Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced initial...
Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that initial...
The latest update is out from Neurogene (NGNE). Neurogene Inc. has struck new employment deals with its top executives, setting significant compens...
This is a signal that NGNE's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...
Neurogene Inc. (NGNE) has released an update. Neurogene Inc., a biotech firm listed on The Nasdaq Global Market under the ticker NGNE, has recently...
Neurogene Inc. (NASDAQ:NGNE Get Free Report)s stock price shot up 5.2% during mid-day trading on Monday . The company traded as high as $52.52 and last traded at $52.48. 30,491 shares...
Neurogene Inc. (NASDAQ:NGNE Free Report) Research analysts at HC Wainwright issued their FY2025 earnings estimates for Neurogene in a research note issued on Tuesday, March 19th...
Key Financials and Clinical Trial Updates HighlightedRelated Stocks: NGNE...
This is a Bullish indicator signaling NGNE's price could rise from here. Traders may explore going long the stock or buying call options...